Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
33.99
+0.12 (0.35%)
At close: Mar 9, 2026, 4:00 PM EDT
34.00
+0.01 (0.02%)
After-hours: Mar 9, 2026, 7:24 PM EDT
Corcept Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 3,616 | 3,661 | 5,280 | 3,348 | 2,186 | 2,097 | |
| Market Cap Growth | -46.98% | -30.67% | 57.69% | 53.13% | 4.24% | -30.98% | |
| Enterprise Value | 3,084 | 3,143 | 4,739 | 2,933 | 1,787 | 1,603 | |
| Last Close Price | 33.94 | 34.80 | 50.39 | 32.48 | 20.31 | 19.80 | |
| PE Ratio | 41.45 | 37.29 | 37.78 | 31.74 | 21.59 | 18.64 | |
| Forward PE | 88.52 | 55.53 | 32.11 | 32.61 | 19.95 | 21.01 | |
| PS Ratio | 4.74 | 4.81 | 7.82 | 6.94 | 5.44 | 5.73 | |
| PB Ratio | 5.55 | 5.65 | 7.77 | 6.61 | 4.36 | 5.58 | |
| P/TBV Ratio | 5.57 | 5.65 | 7.77 | 6.61 | 4.36 | 5.58 | |
| P/FCF Ratio | 25.46 | 25.82 | 26.92 | 26.46 | 18.23 | 12.53 | |
| P/OCF Ratio | 25.43 | 25.78 | 26.63 | 26.43 | 18.17 | 12.49 | |
| PEG Ratio | - | - | - | - | - | 1.50 | |
| EV/Sales Ratio | 4.05 | 4.13 | 7.02 | 6.08 | 4.45 | 4.38 | |
| EV/EBITDA Ratio | 67.12 | 68.40 | 34.40 | 27.08 | 15.69 | 12.73 | |
| EV/EBIT Ratio | 68.84 | 70.15 | 34.60 | 27.34 | 15.87 | 12.88 | |
| EV/FCF Ratio | 21.75 | 22.17 | 24.16 | 23.18 | 14.90 | 9.58 | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0 | 0.00 | 0.00 | |
| Debt / EBITDA Ratio | 0.13 | 0.13 | 0.05 | 0.00 | 0.01 | 0.00 | |
| Debt / FCF Ratio | 0.04 | 0.04 | 0.04 | 0.00 | 0.01 | 0.00 | |
| Net Debt / Equity Ratio | -0.81 | -0.81 | -0.88 | -0.84 | -0.87 | -0.89 | |
| Net Debt / EBITDA Ratio | -11.45 | -11.45 | -4.33 | -3.93 | -3.82 | -2.66 | |
| Net Debt / FCF Ratio | -3.71 | -3.71 | -3.04 | -3.36 | -3.63 | -2.00 | |
| Asset Turnover | 0.91 | 0.91 | 0.92 | 0.80 | 0.80 | 0.74 | |
| Inventory Turnover | 1.03 | 1.03 | 1.08 | 0.94 | 0.97 | 1.07 | |
| Quick Ratio | 2.60 | 2.60 | 3.11 | 4.05 | 6.60 | 5.31 | |
| Current Ratio | 2.92 | 2.92 | 3.35 | 4.39 | 6.89 | 5.61 | |
| Return on Equity (ROE) | 15.02% | 15.02% | 23.81% | 21.05% | 23.11% | 25.03% | |
| Return on Assets (ROA) | 3.34% | 3.34% | 11.71% | 11.13% | 13.98% | 15.63% | |
| Return on Invested Capital (ROIC) | 17.98% | 15.32% | 54.21% | 87.09% | 87.74% | 94.15% | |
| Return on Capital Employed (ROCE) | 6.70% | 6.70% | 19.60% | 20.80% | 22.00% | 33.10% | |
| Earnings Yield | 2.72% | 2.72% | 2.67% | 3.17% | 4.64% | 5.36% | |
| FCF Yield | 3.93% | 3.87% | 3.72% | 3.78% | 5.48% | 7.98% | |
| Buyback Yield / Dilution | -5.73% | -5.73% | -1.55% | 3.64% | 7.94% | -1.42% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.